Sab Biotherapeutics Investment Banking Pitch Decks

Browse 1 presentations in Sab Biotherapeutics. Search by topic, industry, or year.

I'm feeling lucky

1–1 of 1 presentations

Sab Biotherapeutics — Efficacy and Safety of SAB-176, a Novel Anti-Type A and B Influenza Immunotherapeutic: A Phase 2a, Randomized, Double-Blind Trial in H1N1 Challenged Adults investment banking deck cover

Sab Biotherapeutics — Efficacy and Safety of SAB-176, a Novel Anti-Type A and B Influenza Immunotherapeutic: A Phase 2a, Randomized, Double-Blind Trial in H1N1 Challenged Adults

2022

Sab Biotherapeutics · Health & Biotech

12 slides